The Innovative Medicines Initiative launches call on Ebola and other filoviral haemorrhagic fevers

摘要

On 6 November 2014, the Innovative Medicines Initiative 2Joint Undertaking (IMI2 JU) [1] launched its second Call forProposals in the framework of the IMI2 ‘Ebola and otherfiloviral haemorrhagic fevers programme (the Ebola+ pro-gramme)’ [2]. Submissions for the Call can be made as of 22November and closes on 1 December, and has an indicativebudget of € 140 million.